|
|
|
Volumn 10, Issue 7 Suppl, 2001, Pages 15-18
|
|
Economic and quality-of-life impact of rheumatoid arthritis.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI INFLAMMATORY AGENTS, NON STEROIDAL;
ISOXAZOLE DERIVATIVE;
LEFLUNOMIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
CLINICAL TRIAL;
COST OF ILLNESS;
ECONOMICS;
HEALTH INSURANCE;
HUMAN;
PATHOPHYSIOLOGY;
QUALITY OF LIFE;
REVIEW;
RHEUMATOID ARTHRITIS;
TREATMENT OUTCOME;
UNITED STATES;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS;
COST OF ILLNESS;
HUMAN;
ISOXAZOLES;
MANAGED CARE PROGRAMS;
QUALITY OF LIFE;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 0035408098
PISSN: 10623388
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (13)
|
|
References (23)
|
